Gene Information | |
---|---|
Gene Name | YAP65 |
Organism | Homo sapiens (Human) |
Gene Length | 504 |
Protein Names | Transcriptional coactivator YAP1 (Yes-associated protein 1) (Protein yorkie homolog) (Yes-associated protein YAP65 homolog) |
Target Name | NA |
Target Type | NA |
Gene Age | NA |
Evolutionary Stage | NA |
AlphaFoldDB | P46937 |
Gene Card | YAP1 |
Uniprot ID | P46937 |
Pfam | PF00397 |
In ASD | no |
Allosteric Prediction | NA |
Ortholog in Animals | NA |
Ohnologs | NA |
Paralogs | NA |
Tissue | NA |
Tissue Specificity | Increased expression seen in some liver and prostate cancers. Isoforms lacking the transactivation domain found in striatal neurons of patients with Huntington disease (at protein level). {ECO:0000269|PubMed:16461361, ECO:0000269|PubMed:17974916, ECO:0000269|PubMed:7782338}. |
Pharmacological Animal Models | NULL(Chimpanzee);NULL(Mouse);0.008084(Rat);0.054334(Rabbit) |
Gene Ontology (biological process) |
|
Gene Ontology (cellular component) |
|
Gene Ontology (molecular function) |
|
PDB | 1JMQ (NMR - ) 1K5R (NMR - ) 1K9Q (NMR - ) 1K9R (NMR - ) 2LAW (NMR - ) 2LAX (NMR - ) 2LAY (NMR - ) 2LTV (NMR - ) 2LTW (NMR - ) 3KYS (X-ray 2.80A ) 3MHR (X-ray 1.15A ) 4RE1 (X-ray 2.20A ) 4REX (X-ray 1.60A ) 5OAQ (X-ray 1.95A ) 5YDX (NMR - ) 5YDY (NMR - ) 6G6X (X-ray 1.13A ) 6G8I (X-ray 1.60A ) 6G8J (X-ray 1.47A ) 6G8K (X-ray 1.25A ) 6G8L (X-ray 1.37A ) 6G8P (X-ray 1.90A ) 6G8Q (X-ray 1.85A ) 6GE3 (X-ray 1.85A ) 6GE4 (X-ray 1.97A ) 6GE5 (X-ray 2.05A ) 6GE6 (X-ray 1.80A ) 6GEC (X-ray 1.70A ) 6GEE (X-ray 1.96A ) 6GEG (X-ray 2.23A ) 6GEI (X-ray 1.65A ) 6GEK (X-ray 2.28A ) 6HIK (X-ray 1.65A ) 6HIL (X-ray 2.30A ) 6Q2X (X-ray 2.10A ) 7O07 (X-ray 1.20A ) |
DBSNP | rs1162286204 rs376161041 rs777949318 |
Subcellular location [CC] | Cytoplasm {ECO:0000269|PubMed:18158288, ECO:0000269|PubMed:18280240, ECO:0000269|PubMed:20048001, ECO:0000269|PubMed:22525271, ECO:0000269|PubMed:25849865}. Nucleus {ECO:0000269|PubMed:17974916, ECO:0000269|PubMed:18158288, ECO:0000269|PubMed:18280240, ECO:0000269|PubMed:20048001, ECO:0000269|PubMed:21145499, ECO:0000269|PubMed:22525271, ECO:0000269|PubMed:25849865, ECO:0000269|PubMed:28169360, ECO:0000269|PubMed:30447097}. Note=Both phosphorylation and cell density can regulate its subcellular localization (PubMed:18158288, PubMed:20048001). Phosphorylation sequesters it in the cytoplasm by inhibiting its translocation into the nucleus (PubMed:18158288, PubMed:20048001). At low density, predominantly nuclear and is translocated to the cytoplasm at high density (PubMed:18158288, PubMed:20048001, PubMed:25849865). PTPN14 induces translocation from the nucleus to the cytoplasm (PubMed:22525271). Localized mainly to the nucleus in the early stages of embryo development with expression becoming evident in the cytoplasm at the blastocyst and epiblast stages (By similarity). {ECO:0000250|UniProtKB:P46938, ECO:0000269|PubMed:18158288, ECO:0000269|PubMed:20048001, ECO:0000269|PubMed:22525271, ECO:0000269|PubMed:25849865}. |
Mouse PG classification | NA |
click here to return to the previous page |